Cargando…
Dexmedetomidine suppresses the progression of esophageal cancer via miR-143-3p/epidermal growth factor receptor pathway substrate 8 axis
Esophageal cancer is one of the fatal cancers around the world. Dexmedetomidine (DEX) is widely used during anesthesia of esophageal cancer surgery. Nevertheless, the role of DEX in the progression of esophageal cancer remains barely known. The proliferation, apoptosis and metastasis of esophageal c...
Autores principales: | Zhang, Peisen, He, Hefan, Bai, Yuyan, Liu, Weifeng, Huang, Lirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365679/ https://www.ncbi.nlm.nih.gov/pubmed/32701250 http://dx.doi.org/10.1097/CAD.0000000000000934 |
Ejemplares similares
-
Effects of dexmedetomidine on immune function, renal function and inflammatory factors of patients undergoing percutaneous nephrolithotomy under general anesthesia
por: Bai, Yuyan, et al.
Publicado: (2021) -
LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer
por: Wang, Ansheng, et al.
Publicado: (2019) -
Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis
por: Zhang, Qing, et al.
Publicado: (2015) -
Cardiac GRK2 and the Communicative Axis Between Heart and Fat
por: Hill, Bradford G.
Publicado: (2022) -
HDAC6 Regulates the MRTF-A/SRF Axis and Vascular Smooth Muscle Cell Plasticity
por: Zhang, Mengxue, et al.
Publicado: (2018)